Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end...
SEATTLE, Nov. 5, 2021 /PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end of 2028. Cannabidiol
DehydraTECH-CBD also being evaluated in three other human clinical studiesPositive studies would support Lexaria's regulatory approval plansKELOWNA, BC / ACCESSWIRE / November 3, 2021 / Lexaria Bioscience
Highlights:In Q4, explosive gross profit growth (up 179% vs. Q4 FY2020) driven by addition of high-margin DehydraTECH licensing revenues; strong net revenue growth of 60% vs. Q4 FY2020 For the full fiscal
Highlights: In Q4, explosive gross profit growth driven by addition of high-margin DehydraTECH™ licensing revenues; strong net revenue growth of 60% vs. Q4 FY2020 For the full fiscal year, increased gross profits by 55% and grew net revenue by 27% vs. previous fiscal year, despite the pandemic Added two new lines of business to legacy alcohol-free beverage business - 1) cannabis-infused beverage sales and 2) ...